These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2553845)
1. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. Fyhrquist F; Karppinen K; Honkanen T; Saijonmaa O; Rosenlöf K J Intern Med; 1989 Oct; 226(4):257-60. PubMed ID: 2553845 [TBL] [Abstract][Full Text] [Related]
2. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. Adigun AQ; Ajayi AA Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008 [TBL] [Abstract][Full Text] [Related]
3. Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure. Todd PA; Goa KL Drugs; 1989 Feb; 37(2):141-61. PubMed ID: 2539290 [TBL] [Abstract][Full Text] [Related]
4. The effect of enalapril on cardiac arrhythmias in patients with congestive heart failure. Sniezek-Maciejewska M; Czarnecka D; Mroczek-Czernecka D; Kawecka-Jaszcz K Cor Vasa; 1992; 34(5-6):382-9. PubMed ID: 1285055 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of long-term treatment with enalapril in patients with congestive heart failure]. Cannavà G; Buttafarro A; Mangano A; Silipigni C; Cordiani A; Casella F; Pavia L Cardiologia; 1990 Jun; 35(6):485-7. PubMed ID: 2127733 [TBL] [Abstract][Full Text] [Related]
6. Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group. Davies RF; Beanlands DS; Nadeau C; Phaneuf D; Morris A; Arnold JM; Parker JO; Baigrie R; Latour P; Klinke WP J Am Coll Cardiol; 1991 Dec; 18(7):1602-9. PubMed ID: 1960303 [TBL] [Abstract][Full Text] [Related]
7. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. McKelvie RS; Yusuf S; Pericak D; Avezum A; Burns RJ; Probstfield J; Tsuyuki RT; White M; Rouleau J; Latini R; Maggioni A; Young J; Pogue J Circulation; 1999 Sep; 100(10):1056-64. PubMed ID: 10477530 [TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698 [TBL] [Abstract][Full Text] [Related]
9. [Enalapril in treatment of severe heart failure in patients with dilated cardiomyopathy]. Kawecka-Jaszcz K; Czarnecka D; Mroczek-Czernecka D; Dubiel JP Pol Arch Med Wewn; 1994 Jan; 91(1):45-50. PubMed ID: 8190655 [TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic study of a single oral dose of enalapril in patients with heart failure]. Zhi G; Huang DX; Yang XS Zhonghua Nei Ke Za Zhi; 1989 Sep; 28(9):534-6, 572. PubMed ID: 2560702 [TBL] [Abstract][Full Text] [Related]
11. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864 [TBL] [Abstract][Full Text] [Related]
13. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Volpe M; Tritto C; Testa U; Rao MA; Martucci R; Mirante A; Enea I; Russo R; Rubattu S; Condorelli GL Am J Cardiol; 1994 Sep; 74(5):468-73. PubMed ID: 8059727 [TBL] [Abstract][Full Text] [Related]
14. Comparison of enalapril versus digoxin for congestive heart failure. Beaune J Am J Cardiol; 1989 Feb; 63(8):22D-25D. PubMed ID: 2537562 [TBL] [Abstract][Full Text] [Related]
15. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. Johnson G; Carson P; Francis GS; Cohn JN Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237 [TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effect of converting enzyme inhibitors in congestive heart failure. Gürlek A; Erol C; Basesme E Int J Cardiol; 1994 Mar; 43(3):315-8. PubMed ID: 7514156 [TBL] [Abstract][Full Text] [Related]
17. Clinical studies of enalapril treatment for patients with severe congestive heart failure. Sato T; Takeshi M; Yamamoto A Jpn Circ J; 1992 Jan; 56(1):35-45. PubMed ID: 1538575 [TBL] [Abstract][Full Text] [Related]
18. Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin. Jensen JD; Eiskjaer H; Bagger JP; Pedersen EB J Intern Med; 1993 Feb; 233(2):125-30. PubMed ID: 8433072 [TBL] [Abstract][Full Text] [Related]
19. Enalapril in chronic heart failure, a double-blind placebo-controlled study. Remes J; Nikander P; Rehnberg S; Halinen MO; Kuikka J; Länsimies E; Pyörälä K Ann Clin Res; 1986; 18(3):124-8. PubMed ID: 3017174 [TBL] [Abstract][Full Text] [Related]
20. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]